Clinical Trial

A Study of Methylprednisolone in People Having Liver Surgery

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test whether receiving methylprednisolone before surgery will reduce the side effects of having surgery, such as infections and longer hospital stays.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-27.
Trial Details
NCT Number NCT07507643
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Hepatectomy
Enrollment 750 participants
Start Date 2026-03-27
Primary Completion 2029-03-27 (estimated)
Study Completion 2029-03-27 (estimated)
Updated on ClinicalTrials.gov 2026-07-07